Millions of people live with chronic nerve pain every day. Unlike the pain from a cut or a broken bone, nerve pain can continue for months or even years. It happens when nerves become damaged or stop working properly.
The damaged nerves keep sending pain signals to the brain even when there is no new injury. This condition, known as neuropathic pain, can cause burning, stabbing, tingling, or electric shock-like feelings. For many people, the pain is severe enough to interfere with sleep, work, exercise, and everyday activities.
Treating chronic nerve pain is often difficult. Doctors usually prescribe medicines such as gabapentin, which was first developed to treat epilepsy, or duloxetine, which is commonly used to treat depression. These medicines help some patients, but they do not work well for everyone.
They can also cause side effects including dizziness, tiredness, sleepiness, and mood changes. In some cases, doctors may prescribe opioid painkillers. Although opioids can reduce pain, they carry serious risks such as addiction, dependence, overdose, and death. Because of these problems, scientists have spent many years searching for safer and more effective treatments.
A new study from researchers at Weill Cornell Medicine and the Burke Neurological Institute offers fresh hope. Their research describes a new drug that reduced chronic nerve pain in animal studies without causing the harmful side effects commonly linked to opioids. The findings represent an important step toward developing a completely new way of treating nerve pain.
The research focused on tiny proteins called HCN ion channels. These proteins help control the electrical activity of nerve cells. When the channels become too active, they can make damaged nerves send constant pain messages to the brain.
Scientists have known about these channels for years, but creating a medicine that safely blocks them has been a major challenge. The reason is that HCN channels are also found in the heart and brain. A drug that blocks them everywhere in the body could cause dangerous heart problems or unwanted effects such as drowsiness.
To solve this problem, Dr. Gareth Tibbs and his team designed a new drug called BP4L-18:1:1. The medicine was created from propofol, a well-known anesthetic that doctors use to keep patients asleep during surgery.
The researchers changed the chemical structure of propofol by adding what they describe as a special chemical anchor. This anchor keeps the medicine away from the brain while allowing it to reach the damaged nerves outside the brain and spinal cord.
The idea is similar to a boat tied to an anchor. The boat can still move with the water, but it stays in the area where it is needed. In the same way, the chemical anchor helps keep the drug in the right part of the body so it mainly acts on the nerves responsible for chronic pain instead of affecting the heart or brain.
When the researchers tested the medicine in rats with chronic nerve pain, the results were encouraging. The drug worked when given as a pill and significantly reduced pain. Just as importantly, the animals did not show the harmful side effects that scientists worry about with many existing pain medicines.
While these results are still early, they suggest that the new approach could one day provide effective pain relief with a much lower risk of addiction or other serious complications.
The researchers are now working toward clinical trials in people. Human studies are necessary to find out whether the medicine is both safe and effective outside the laboratory. If future studies are successful, this treatment could offer a valuable new option for millions of people whose pain is not well controlled by current medicines.
Dr. Steven Fox, founder of Akelos, the company helping develop the treatment, said the new medicine has the potential to change the way chronic nerve pain is treated because it targets the underlying cause of pain while avoiding many harmful side effects.
The research was supported by the Daedalus Fund for Innovation, which helps move promising scientific discoveries toward real medical treatments.
Although more testing is still needed, the study offers real hope for the future. Chronic nerve pain affects millions of people worldwide, and many continue to struggle despite available treatments. A safer medicine that relieves pain without the dangers of opioid addiction could improve the lives of countless patients and their families.
The research was carried out by scientists at Weill Cornell Medicine and the Burke Neurological Institute and supports continued efforts to develop a new generation of safer pain medicines.
If you care about pain, please read studies about how to manage your back pain, and Krill oil could improve muscle health in older people.
For more health information, please see recent studies about how to live pain-free with arthritis, and results showing common native American plant may help reduce diarrhea and pain.
Copyright © 2026 Knowridge Science Report. All rights reserved.
